FOLR1 and non-small cell lung carcinoma: Previous reports that FRA expression may vary by non-small cell lung cancer (NSCLC) histological subtype and that expression levels may be associated with disease stage or survival in lung adenocarcinoma suggest that FRA may be a useful diagnostic and prognostic marker [5, 6].